Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 7, pseudogene (RNU1-7P)
- Target
- RNU1-7P
- Molecular classification
- Other (pseudogene), Non-coding RNA gene (does not encode for protein)
01
Overview
RNU1-7P (RNA, U1 small nuclear 7, pseudogene) is a genomic locus classified as a small nuclear RNA (snRNA) pseudogene. U1 snRNA genes are essential components of the spliceosome machinery for pre-mRNA splicing, but RNU1-7P is a non-coding pseudogene and does not encode a functional protein or snRNA. Some U1 pseudogenes, termed "variant U1 snRNAs," have been shown to be transcribed, processed, and incorporated into ribonucleoprotein complexes, where they may play regulatory roles in RNA processing and gene expression. The relevance and functions of specific pseudogenes like RNU1-7P are unclear, and there is no evidence it serves as a therapeutic target or receptor. It is not associated with any interacting drugs, known biomarkers, or clinical safety issues. Its primary significance is academic, relating to gene regulation and pseudogene biology.
- Other names
- RNU1-7PRNU1-7RNA, U1 small nuclear 7, pseudogene
02
Mechanism of action
None. No drugs target RNU1-7P, so no mechanisms of action are described.
03
Biological functions
Possible regulatory RNA functions (based on related U1 snRNA pseudogenes)May generate variant U1 small nuclear RNAs (vU1 snRNAs) that are incorporated into ribonucleoprotein complexes and can participate in RNA processing, including 3′ end processing of pre-mRNAsNo identified canonical role in signal transduction, cell cycle, apoptosis, immune response, cell proliferation, or cell death as a protein coding gene
04
Disease associations
Other.No established link to major diseases such as cancer, inflammation, neurodegenerative disease, cardiovascular disease, or infection as a direct target.More generally, functional pseudogenes may participate in regulation of gene expression, but specific roles for RNU1-7P are not documented.
05
Safety considerations
None. As a pseudogene with no direct functional protein product or clinical targeting, there are no safety concerns or therapeutic challenges associated
Beyond the preview
Go deeper on RNA, U1 small nuclear 7, pseudogene (RNU1-7P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U1 small nuclear 7, pseudogene (RNU1-7P).